U.S., April 19 -- ClinicalTrials.gov registry received information related to the study (NCT06933238) titled 'Efficacy of Fuzheng Tongfu Jiedu Prescription for Treating Gastrointestinal Dysfunction Associated With Sepsis' on March 20.
Brief Summary: This study is a single-center, randomized, double-blind, placebo-controlled trial.
Study Start Date: April 25
Study Type: INTERVENTIONAL
Condition:
Sepsis Abdominal
Gastrointestinal Dysfunction
Traditional Chinese Medicine
Intervention:
DRUG: Fuzheng Tongfu Jiedu prescription (FZTFJD)
Fuzheng Tongfu Jiedu prescription (FZTFJD), a kind of Traditional Chinese medicine (TCM).Conventional Western medical treatment in accordance with the "2021 International Guidelines for the Management of Se...